Lipoprotein(a) and Oxidized Phospholipids: Partners in Crime or Individual Perpetrators in Cardiovascular Disease?
- PMID: 37137589
- DOI: 10.1016/j.jacc.2023.02.051
Lipoprotein(a) and Oxidized Phospholipids: Partners in Crime or Individual Perpetrators in Cardiovascular Disease?
Keywords: atherosclerosis; coronary artery disease; lipids and lipoproteins; lipoprotein(a).
Conflict of interest statement
Funding Support and Author Disclosures Dr Rader serves on scientific advisory boards for Alnylam and Novartis. Dr Bajaj has received research support from Amgen, Ionis Pharmaceuticals, Kaneka Medical America, Novartis Pharmaceuticals, Pfizer, and Regeneron.
Comment on
-
Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes.J Am Coll Cardiol. 2023 May 9;81(18):1780-1792. doi: 10.1016/j.jacc.2023.02.050. J Am Coll Cardiol. 2023. PMID: 37137588 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
